MedPath

Asthma in the Elderly: A Study of Choline Supplementation

Phase 3
Completed
Conditions
Asthma in the Elderly
Registration Number
NCT02371993
Lead Sponsor
Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
Brief Summary

Asthma in the elderly is poorly understood, as most studies have not included this patient group. In a previous study of adults with asthma, choline supplementation had a positive effect on asthma symptoms and allowed to decrease asthma pharmacologic treatment. The present study is a randomized, double-blind, placebo-controlled, cross-over study of choline supplementation. The investigators will study the effect of choline 650 mg taken orally twice daily x 6 weeks versus placebo on asthma symptom scores (Asthma Control Test) and spirometric values (FEV1, FEV1/FVC, FEF25-75%). The investigators will also look at the effect of choline supplementation on peripheral blood eosinophils, serum immunoglobulin E (IgE) and homocysteine levels.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Asthma
Exclusion Criteria
  • No history of smoking more than 10 pack/years,
  • no gastrointestinal cancers,
  • no liver or kidney disease,
  • no bipolar disorder.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Effect of choline supplementation on spirometric values (FEV1, FEV1/FVC, FEF25-75%)six weeks
Effect of choline supplementation on asthma symptoms measured by the Asthma Control Testsix weeks
Secondary Outcome Measures
NameTimeMethod
Effect of choline supplementation on peripheral blood eosinophilssix weeks
Effect of choline supplementation on serum homocysteine levelssix weeks
Effect of choline supplementation on serum IgEsix weeks

Trial Locations

Locations (1)

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.

🇺🇸

Bryn Mawr, Pennsylvania, United States

Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C.
🇺🇸Bryn Mawr, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.